Agomelatine 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-08
Product Details
- Product NameAgomelatine
- CAS No.138112-76-2
- EINECS No.629-727-7
- MFC15H17NO2
- MW243.3
- Appearancepowderwhite to off-white
- Melting point 107-109°C
- storage temp. 2-8°C
- Boiling point 478.8±28.0 °C(Predicted)
- density 1.109±0.06 g/cm3(Predicted)
Company Profile Introduction
We are one of world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector. We endeavour to serve patients by moulding science and technology into therapies to improve health outcomes and people’s lives.
We leverage our experience of 30 years in developing APIs across diverse therapeutic areas and are a leading supplier to generics manufacturers. We are among the first Indian companies to develop and manufacture affordable APIs for ARVs. Our portfolio includes over 300 APIs across multiple therapeutic segments.
Supplier other products
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- Agomelatin 138112-76-2 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- AKASH PHARMA EXPORTS
- Agomelatine 99%
- Inquiry
- 2024-05-16
-
VIP1年
- Shankus Pharmaceuticals
- Agomelatine 138112-76-2 98%
- Inquiry
- 2024-03-26
-
VIP1年
- Symed Laboratories Ltd
- Agomelatine 98%
- Inquiry
- 2024-03-21
-
VIP1年
- KPS Chemicals And Pharmaceuticals
- Agomelatine 98%
- Inquiry
- 2024-03-15
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- Agomelatine 138112-76-2 98%
- Inquiry
- 2024-02-24
-
VIP1年
- Biophore India Pharmaceuticals Pvt Ltd
- Agomelatine 98%
- Inquiry
- 2024-02-21
-
VIP1年
- Ralington Pharma
- 138112-76-2 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Mehta API Pvt. Ltd.
- 138112-76-2 Agomelatine 98%
- Inquiry
- 2024-01-19
-
VIP1年
- Svak Life Sciences
- Agomelatine 138112-76-2 98%
- Inquiry
- 2024-01-11
- Since:2020-01-01
- Address: "7-2-A2, Hetero Corporate Industrial Estates, Sanath Nagar Hyderabad Telangana"